| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 30.51 | 9.82 | 8.74 | 3.8 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 137.61 | 29.11 | 24.95 | 5.67 |
Net Worth | 168.12 | 38.93 | 33.69 | 9.47 |
Minority Interest | ||||
Debt | 94.12 | 60.66 | 14.75 | 3.71 |
Deferred Tax Liability Net | 0 | 0 | 0 | 0 |
Total Liabilities | 262.24 | 99.59 | 48.44 | 13.18 |
Fixed Assets | 42.56 | 19.1 | 4.76 | 4.41 |
Intangible Assets | ||||
Investments | 81.58 | 8.23 | 11.69 | 1.45 |
Deferred Tax Asset Net | 0.21 | 0.18 | 0.45 | 0.77 |
Networking Capital | 127.45 | 71.98 | 30.13 | 4.91 |
Inventories | 4.52 | 3.12 | 2.98 | 0.34 |
Inventory Days | ||||
Sundry Debtors | 22.01 | 15.73 | 8.37 | 0.23 |
Debtor Days | ||||
Other Current Assets | 124.54 | 65.27 | 25.5 | 6.12 |
Sundry Creditors | -11.63 | -4.39 | -6.05 | -0.13 |
Creditor Days | ||||
Other Current Liabilities | -11.99 | -7.75 | -0.67 | -1.65 |
Cash | 10.44 | 0.09 | 1.41 | 1.64 |
Total Assets | 262.24 | 99.58 | 48.44 | 13.18 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
